<DOC>
	<DOCNO>NCT01733082</DOCNO>
	<brief_summary>The Mycophenolate Pregnancy Registry design prospective , observational registry collect data regard mycophenolate exposure pregnancy , pregnancy outcome , fetal infant outcomes exposure . Early late term pregnancy outcomes solicit select gestational time point . Structural functional birth defect identify perinatal period one year life collect classified . This non-proprietary registry component comprehensive pregnancy Risk Evaluation Mitigation Strategy ( REMS ) plan require FDA mycophenolate-formulations , include CellCept , Myfortic generic formulation .</brief_summary>
	<brief_title>The Mycophenolate Pregnancy Registry</brief_title>
	<detailed_description />
	<mesh_term>Autoimmune Diseases</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>Pregnancy report maternal exposure mycophenolate pregnancy within 6 week discontinue treatment Pregnancies paternal exposure Pregnancies occur outside U.S .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>